Abraxane in Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway
- Status
- COMPLETED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study for Solid Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Study of ESR1 Mutations in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- NA
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
SOLTI Breast Cancer Molecular Screening Program (AGATA)
- Status
- COMPLETED
- Phase
- N/A
Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor
- Status
- COMPLETED
- Phase
- NA
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
- Status
- COMPLETED
- Phase
- N/A